Table 3.
Gene | SNP | Associated with | p-Value | References |
---|---|---|---|---|
CCL2 | rs1024611 | Myocardial infarction | 0.005 and 0.009a | McDermott et al. (2005) |
<0.001 and 0.001b | ||||
Coronary artery disease | <0.005 | Szalai et al. (2001) | ||
CCL5 | rs2107538 | Acute coronary syndrome | 0.0073 | Simeoni et al. (2004) |
Coronary artery disease | 0.0038 | |||
CCL11 | rs1129844 | Myocardial infarction | 0.012 and 0.008c | Zee et al. (2004) |
CXCL5 | rs352046 | Acute coronary syndrome | 0.005 | Zineh et al. (2008) |
CXCL8 | rs4073 | Acute coronary syndrome | 0.004 | Zhang et al. (2011) |
CXCL12 | rs1746048 | Myocardial infarction (early onset) | 1 × 10−8 | Kathiresan et al. (2009) |
Atherosclerosis severity and progression | 0.009 | Kiechl et al. (2010) | ||
Coronary artery disease | 3 × 10−10 | Schunkert et al. (2011) | ||
rs1801157 | Myocardial infarction | 0.007 | Luan et al. (2010) | |
rs501120 | Coronary heart disease | 1.4 × 10−6 | Franceschini et al. (2011) | |
Myocardial infarction | 0.002 | Qi et al. (2011) | ||
Coronary artery disease | 9.46 × 10-8 | Samani et al. (2007) | ||
CCR2 | rs1799864 | Heart failure | 0.015 | Ortlepp et al. (2003) |
Myocardial infarction | 0.007 | Ortlepp et al. (2003) | ||
0.054d | Petrkova et al. (2003) | |||
rs34948438 | Myocardial infarction | 0.0013e | Karaali et al. (2010) | |
0.0016f | ||||
CCR5 | rs333 | Myocardial infarction | 0.001 | Kallel et al. (2012) |
0.0013 | Karaali et al. (2010) | |||
Severe calcific aortic stenosis | 0.037g | Ortlepp et al. (2004) | ||
Myocardial infarction | 0.003h | Singh et al. (2012) | ||
CX3CR1 | rs3732379 | Coronary artery disease | 0.03 | McDermott et al. (2001) |
Acute coronary syndrome | 0.001 | Moatti et al. (2001) | ||
Single in-stent restenosis | 0.006 | Niessner et al. (2005) | ||
Recurrent in-stent restenosis | 0.011 | |||
Myocardial infarction | 0.006i | Singh et al. (2012) |
aIn multivariable adjustment and multivariable adjustment of pooled-sex cohort, respectively.
bIn multivariable adjustment and multivariable adjustment of male cohort, respectively.
cIn an age and smoking and body mass index, hypertension, diabetes, and randomized treatment assignment adjusted recessive model of inherence, respectively.
dIn female cohort.
eIn patients carrying CCR5 rs34948438 wildtype (wt)/deletion (Δ) genotype.
fIndividuals carrying the CCR5 rs34948438 heterozygote or homozygous variant genotype (Δ/Δ + wt/Δ).
gIn patients carrying the CCR5 rs333 SNP or CTGF -447C allele.
hIn individuals carrying both CCR5 rs1799987 and rs333 SNPs.
iIn individuals carrying both CX3CR1 rs3732378 and rs3732379SNPs.